1 Failure to achieve complete resolution |
6 |
302 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.17 [0.95, 1.44] |
1.1 28% per week |
2 |
81 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.27 [0.65, 2.50] |
1.2 14% per week |
2 |
103 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.06 [0.49, 2.30] |
1.3 2% to 7% per week |
2 |
118 |
Risk Ratio (M‐H, Fixed, 95% CI) |
1.17 [0.97, 1.42] |
2 Failure to achieve complete resolution (long term) |
2 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
2.1 28% per week |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
2.2 2% to 7% per week |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
0.0 [0.0, 0.0] |
3 Erythema ‐ Failure to achieve complete resolution |
2 |
195 |
Risk Ratio (M‐H, Random, 95% CI) |
0.51 [0.19, 1.38] |
3.1 2% to 7% per week |
2 |
195 |
Risk Ratio (M‐H, Random, 95% CI) |
0.51 [0.19, 1.38] |
4 Decrease in scaling score |
5 |
329 |
Std. Mean Difference (IV, Random, 95% CI) |
0.19 [‐0.13, 0.51] |
4.1 14% per week |
2 |
110 |
Std. Mean Difference (IV, Random, 95% CI) |
‐0.02 [‐0.52, 0.48] |
4.2 2% to 7% per week |
3 |
219 |
Std. Mean Difference (IV, Random, 95% CI) |
0.32 [‐0.12, 0.77] |